Medicines4Kids In the Open
Recording of M4K Pharma’s Scientific Update Meeting – March 6th, 2019
Recording of M4K Pharma’s Scientific Update Meeting – March 6th, 2019 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- [...]
M4ND Pharma: Open science drug discovery model expands to neurodegenerative diseases
Medicines for Neurodegeneration (M4ND) Pharma launched! Following in the path of M4K Pharma, M4ND will tackle neurodegenerative diseases such as Parkinson’s disease, thanks to funding from the Krembil Foundation, and will [...]
For Innovation, Open Science Means Open for Business
Richard Gold (McGill University) and Max Morgan (SGC, M4k Pharma) penned an opinion piece in the Globe and Mail discussing how open science projects with no patents can result in [...]
Recording of M4K Pharma’s Scientific Update Meeting – December 4th, 2018.
Recording of M4K Pharma's Scientific Update Meeting - December 4th, 2018 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a [...]
Ideation and implementation of an open science drug discovery business model – M4K Pharma.
Regulatory exclusivity as a primary intellectual property and commercial asset How can a company take advantage of regulatory exclusivity to launch an open science drug discovery program? Max Morgan et [...]
Recording of M4K Pharma’s Scientific Update Meeting – November 6th, 2018.
Recording of M4K Pharma's Scientific Update Meeting - November 6th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- [...]